Erin Clarke, MD
Allergy Physician · Dallas, TX
Erin Clarke, MD is an allergy physician with a practice address in Dallas, Texas, and NPI 1285843599, issued on May 22, 2007. Check the license (Texas N4355, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Erin Clarke
- Credential
- MD
- Primary taxonomy
- Allergy Physician 207KA0200X
- License number
- N4355 TX
Self-reported in NPPES; status is on the state search - Practice location
- 8201 Preston RD Ste 275, Dallas, TX 75225
- Phone
- (469) 310-3681
- Enumerated
- May 22, 2007
- Entity
- Type 1 · individual
Verify Erin Clarke in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license N4355Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
85% fewer Medicare Part D claims than the average allergy physician in 2024
119 Medicare Part D claims for 29 beneficiaries, against an average of 805 among the 637 providers of this specialty who prescribed in Part D. Brand-name drugs were 42% of claims.
Most prescribed
- Trelegy Ellipta20 claims
- Azelastine Hcl13 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $1,530.76
68 payments, mostly food and beverage; the largest payer was Genzyme Corporation. The 486 providers of this specialty with any payment received $7,736.70 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Allergy Physician providers in Texas
There are 70 allergy physician records in Texas.
Other allergy physician records in Texas
- Stuart Abramson, M.D.San Angelo, TX1710984893
- Sasha Alvarado, D.O.Murphy, TX1417377839
- Sheila Amar, M.D.Georgetown, TX1003962689
- Aneesh Angirekula, MDHouston, TX1770046146
- Pedro Avila, MDSpring, TX1356312011
- Suzanne Beck, M.D.Lubbock, TX1861597973
- Christodoulos Christodoulou, M.D.San Angelo, TX1700140969
- Renee Clary, PA-CBellaire, TX1841474459
- Harold Delasalas, PHARMD, MDDuncanville, TX1538329198
- Patricia Dinger, D.O.San Antonio, TX1770709370
Common questions
What is Erin Clarke, MD's NPI number?
Erin Clarke, MD's National Provider Identifier (NPI) is 1285843599, issued on May 22, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Erin Clarke, MD located?
The NPPES record lists a practice address at 8201 Preston RD Ste 275, Dallas, TX, 75225. Phone: (469) 310-3681. Providers update this record themselves, so call before visiting.
How can I verify Erin Clarke, MD's license?
NPPES lists Texas license number N4355, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Erin Clarke, MD prescribe under Medicare Part D?
In 2024, Erin Clarke, MD had 119 Medicare Part D claims for 29 beneficiaries; the average among allergy physician prescribers was 805. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.